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Protocol: The Effects of Medical Cannabis on Pain and Quality of Life in
Individuals with Parkinson’s Disease and/or Chronic Pain
Maureen R. Pascal, PT, DPT, NCS; Patrick T. DeMichele, SPT; Jenna M. Hiryak, SPT;
Hailey S. Inge, SPT; Olivia J. Meyer, SPT.
BACKGROUND

PARTICIPANTS

FURTHER RESEARCH

The earliest evidence of cultivation of cannabis comes
from a small village in China in 4000 BCE.

The sample that will be gathered will be collected by
convenience at the Ethos Cannabis Dispensary in Wilkes
Barre, PA.

Continued research is needed to study links between
medical cannabis, Parkinson’s disease, and chronic pain.

Cannabis was once worshipped and seen in value as it
was known to be one of the 5 main grains. Used widely
for its medicinal purposes and recreationally. It was
shown to be helpful in treatment of over 100 ailments.
Cannabinoids and Terpenes make up a majority of
cannabis.
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The most prevalent cannabinoids are
Tetrahydrocannabinol (THC) and cannabidiol (CBD).
Cannabinoids bind to Cannabinoid receptors to initiate
therapeutic effects.

Participants will be new or current customers at the
dispensary and will have a certification and prescription
to use medical cannabis in the state of Pennsylvania.
From this group, we will invite patients who are
currently diagnosed with Parkinson’s disease, chronic
pain, or both to participate in our study.
We are aiming to obtain a total of 100 participants that
will complete our survey.

CB1 receptor is present in the CNS and is responsible for
regulating sleep, appetite, perception of time, short term
memory and coordination.

Inclusion Criteria:
Individuals 18 years of age or older
Diagnosis of chronic pain, Parkinson's disease or both
Are able to understand English

CB2 receptor present on cells of the immune system
and is responsible for regulating pain, inflammation, and
tissue damage.

Exclusion Criteria:
Individuals with other neurological diagnoses (Stroke
or Spinal Cord Injury)

METHODS
The electronic survey will be available via a QR code
displayed on the flyer that will be hung in the Ethos
Cannabis lobby.
Paper copies of the survey will also be available upon
request. The paper copies will include a pre-addressed
and stamped return envelope addressed to Maureen
Pascal at Misericordia University.
Hemp vs Marijuana: A Beginner’s Guide. Kender. https://www.kenderhealth.com/2020/02/20/hemp-vs-marijuana-a-beginners-guide/. Accessed April 12, 2021.11

PURPOSE & HYPOTHESIS
The purpose of this study is to determine the effects of
medical cannabis and its impact on the quality of life and
pain levels for those with Parkinson's disease and/or
chronic pain.
We hypothesize that medical cannabis will reduce pain
and increase quality of life in patients with Parkinson’s
disease and chronic pain.

Research is needed to study the impact of the use of
medical cannabis on individual’s participation in Physical
Therapy.

CONSIDERATIONS
State Medical Marijuana Laws. NCSL.org. https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx. Published April 5, 2021. Accessed April 12, 2021.

OUTCOME MEASURES
Pain
Wong-Baker FACES Pain Rating Scale

Quality of Life
Life Satisfaction Questionnaire-11 (LISAT-11)
Life as a whole
Vocation
Financial
Leisure
Contact with friends and acquaintances
Sexual life
Self-care management
Family life
Partnership
Physical health
Psychological health

Upon completion, participants may contact Maureen
Pascal via the email provided to receive a free $5 gift
card to Dunkin.

PHYSICAL THERAPY IMPLICATIONS

The survey has been constructed by the researchers to
evaluate physical, mental, and pain status before and
after medical cannabis use.

Increase awareness of the possible effects/benefits of
medical cannabis for individuals with Parkinson’s
Disease and/or chronic pain.

Oral delivery methods will be noted on the survey to
acknowledge any effects that route of administration
have on the results of the study.

Be able to discuss alternative medicines with patients
and other healthcare providers.

As of April 2016, cannabis has been approved for
medicinal use in the state of Pennsylvania.
Increased support at the state level may promote the
use of medical cannabis for many medical conditions.
There is currently limited support at the federal level
regarding the use of medical cannabis.
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